Encyclopedia of Pharmacy Practice and Clinical Pharmacy

Encyclopedia of Pharmacy Practice and Clinical Pharmacy

1st Edition - June 20, 2019
This is the Latest Edition
  • Editor-in-Chief: Zaheer-Ud-Din Babar
  • eBook ISBN: 9780128127360
  • Hardcover ISBN: 9780128127353

Purchase options

Purchase options
DRM-free (PDF)
Available
Sales tax will be calculated at check-out

Institutional Subscription

Free Global Shipping
No minimum order

Description

Encyclopedia of Pharmacy Practice and Clinical Pharmacy, Three Volume Set covers definitions, concepts, methods, theories and applications of clinical pharmacy and pharmacy practice. It highlights why and how this field has a significant impact on healthcare. The work brings baseline knowledge, along with the latest, most cutting-edge research. In addition, new treatments, algorithms, standard treatment guidelines, and pharmacotherapies regarding diseases and disorders are also covered. The book's main focus lies on the pharmacy practice side, covering pharmacy practice research, pharmacovigilance, pharmacoeconomics, social and administrative pharmacy, public health pharmacy, pharmaceutical systems research, the future of pharmacy, and new interventional models of pharmaceutical care. By providing concise expositions on a broad range of topics, this book is an excellent resource for those seeking information beyond their specific areas of expertise. This outstanding reference is essential for anyone involved in the study of pharmacy practice.

Key Features

  • Provides a ‘one-stop’ resource for access to information written by world-leading scholars in the field
  • Meticulously organized, with articles split into three clear sections, it is the ideal resource for students, researchers and professionals to find relevant information
  • Contains concise and accessible chapters that are ideal as an authoritative introduction for non-specialists and readers from the undergraduate level upwards
  • Includes multimedia options, such as hyperlinked references and further readings, cross-references and videos

Readership

Pharmacy students, biomedical students and researchers, clinical pharmacists, hospital pharmacists, clinical trials specialists, pharmaceutical industry, biomedical researchers, specialists and doctors, post graduate and undergraduate students. Pharmaceutical Policy makers, hospital administrators, international agencies, scientific and biomedical organisations, research and advocacy organisations will also benefit

Table of Contents

  • Articles (tentative)

    102. Becoming a pharmacist: education and training

    103. Becoming a pharmacy assistant and technician: education and training

    104. Certification, credentialing and privileging in clinical pharmacy

    105. Clinical pharmacy professional standards in Australia and New Zealand

    106. Clinical pharmacy professional standards in European Union

    107. Clinical pharmacy professional standards in low and middle income countries

    109. Clinical pharmacy professional standards in United Kingdom

    110. Clinical pharmacy professional standards in United States of America and Canada

    111. Competency standards for clinical pharmacists

    112. Continuing professional development for clinical pharmacists

    114. Developing and evaluating clinical skills

    115. Dymanic relationship between education, regulation and practice

    116. Experiental education for clinical pharmacists

    118. Indicators of quality in community settings

    119. Indicators of quality in hospital settings

    120. Interprofessional clinical education

    121. Leadership in Pharmacy

    122. Learning and teaching methods to develop clinical skills

    123. Needs based education

    124. Patient safety standards

    125. Professional standards defining quality services

    126. Professionalism as the core competency in pharmacy

    127. Quality assurance and quality advancement of pharmacy education

    128. Pharmacy Education and Practice in Jordan

    129. Using patients and simulation in teaching clinical skills

    130. Service learning and competence development for pharmacist

    131. Pharmacist workforce issues

    201. Definitions and principles, and concepts of pharmacoepidemiology and pharmacovigilance

    202. Descriptive and drug utilisation studies

    203. Case-control studies

    204. Cohort studies

    205. Methodological challenges in epidemiological studies

    206. Sources of data used in pharmacoepidemiology and pharmacovigilance studies

    207. Special population studies to inform medication safety – paediatrics

    208. Special population studies to inform medication safety – geriatrics

    209. Comparative effectiveness studies

    210. Economic evaluation of pharmaceuticals studies

    211. Methodological considerations in pharmacoepidemiology and pharmacovigilance studies

    212. Application of pharmacoepidemiology and pharmacovigilance studies

    301. Access to biosimilars

    302. Access to high cost medicines

    303. Adherence, compliance and concordance

    304. Advertising of prescription medicines

    305. Ageing populations and medicine use: A sociological approach

    306. Pharmacists in general practice - an ethnographic perspective

    307. Changing Behaviour

    308. Changing nature/status of pharmacy as a profession and occupation

    309. Community pharmacy operations and management

    312. Counterfeit medicines

    313. The Impact of Culture and Religion on Medicine USe

    314. Disease mongering

    315. Factors influencing pharmaceutical policy implementation

    316. Funding mechanisms for Community Pharmacy service provision

    318. Gender trends in pharmacy (global, feminsation, masculinisation…)

    319. Generic drug policies

    320. Health & Illness beliefs

    321. Health literacy

    322. Health psychology and pharmacy practice

    323. Managing cultural diversity in pharmacy practice

    325. Marketing of pharmaceutical services

    326. Medication narratives

    328. National medicine policies impacting on pharmacy practice

    329. Pharmaceutical company sponsored medication assistance programs

    330. Pharmaceutical pricing policies

    331. Pharmaceuticalisation of people

    332. Pharmaceuticals and national health insurance programmes

    335. Prescribing behaviours

    336. Prescription dispensing through online pharmacies

    337. Public and patient engagement

    338. Public perceptions of pharmacy services

    341. Social Pharmacy: concept, development and theories

    342. Sociology for pharmacists

    344. World Health Organization essential medicines list and its impact on improving the use of medicines

    345. Implementation of change in pharmacy practice

    346. Professional Boundaries (IPE)

    347. Social Perspectives in Addiction

    348. Corporatisation

    349. Stigma surrounding medicine use - HIV exemplar

    350. External reference pricing and medicines

    355. Human Factors

    356. Goal Setting

    357. Personal Experiences

    401. Clinical Governance Principles

    402. Clinical pharmacokinetics principles and therapeutic drug monitoring

    403. Clinical pharmacy practice: concepts, history and development

    405. Developing therapeutic guidelines

    406. Poison Information Sources and Typical Guidance & Management of Acute Drug Toxicity

    407. End of life care including pharmaceuticals in palliative care

    408. Fundementals of Pharmaceutical Care planning

    409. Health Outcomes and Quality of Life

    412. Role of pharmacist in provision of clinical services in Military

    413. Role of pharmacist in provision of clinical services in prisons

    416. Long term care

    417. Pharmacogenetics

    418. Pharmacotherapy and deprescribing

    501. Management of cardiovascular disorders and the pharmacist's role: Acute Coronary Syndrome

    502. Management of cardiovascular disorders and the pharmacist's role: Arrhythmias

    503. Management of cardiovascular disorders and the pharmacist's role: Coronary artery disease & dyslipidemia

    504. Management of cardiovascular disorders and the pharmacist's role: Heart Failure

    505. Management of cardiovascular disorders and the pharmacist's role: Hypertension

    506. Management of cardiovascular disorders and the pharmacist's role: Stroke

    507. Management of cardiovascular disorders and the pharmacist's role: Venous thromboembolism and coagulation diso

    508. Management of respiratory disorders and the pharmacist's role: Asthma

    509. Management of respiratory disorders and the pharmacist's role: COPD

    510. Management of respiratory disorders and the pharmacist's role: Cough, colds and Sore throats and allergies (including eyes)

    511. Management of respiratory disorders and the pharmacist's role: Cystic Fibrosis

    512. Management of gastrointestinal disorders and the pharmacist's: Coeliac disease

    513. Management of gastrointestinal disorders and the pharmacist's: Constipation

    577. Management of gastrointestinal orders and the pharmacist's: IBS

    514. Management of gastrointestinal disorders and the pharmacist's: GORD

    515. Management of gastrointestinal disorders and the pharmacist's: Inflammatory bowel disease

    518. Management of renal disorders and the pharmacist's role: Acute Kidney Disease

    519. Management of renal disorders and the pharmacist's role: Chronic Kidney Disease

    520. Management of renal disorders and the pharmacist's role: Renal transplant specialisation

    522. Management of endocrine disorders and the pharmacist's role: Adrenal Insufficiency

    523. Management of endocrine disorders and the pharmacist's role: Diabetes

    525. Management of endocrine disorders and the pharmacist's role: Thyroid

    526. Management of obstetrics and gynaecology disorders and the pharmacist's role: Contraception & ECP

    527. Management obstetrics and gynaecology disorders and the pharmacist's Role: Menopause and HRT

    528. Management of obstetrics and gynaecology disorders and the pharmacist's role: Menstrual disorders

    530. Management of urologic disorders and the pharmacist's role: BPH

    531. Management of urologic disorders and the pharmacist's role: Erectile dysfunction

    532. Management of urologic disorders and the pharmacist's role: Urinary incontinence

    534. Management of rheumatology disorders and the pharmacist's role: Osteoarthritis

    535. Management of rheumatology disorders and the pharmacist's role: Osteoporosis

    536. Management of rheumatology disorders and the pharmacist's role: Rheumatoid Arthritis

    537. Management of eye and ear disorders and the pharmacist's role: Glaucoma

    538. Management of eye and ear disorders and the pharmacist's role: Infective

    539. Management of eye and ear disorders and the pharmacist's role: Common ear disorders

    540. Management of neurological disorders and the pharmacist's role: AD

    541. Management of neurological disorders and the pharmacist's role: Epilepsy

    543. Management of neurological disorders and the pharmacist's role: Pain incl headache

    544. Management of Neurological Disorders and the Pharmacist's Role: Parkinson's Disease

    547. Management of mental health disorders and the pharmacist's role: Anxiety disorders

    548. Management of mental health disorders and the pharmacist's role: Bipolar

    549. Management of mental health disorders and the pharmacist's role: Depression

    550. Management of mental health disorders and the pharmacist's role: Schizophrenia

    551. Management of mental health disorders and the pharmacist's role: Sleep disorders

    552. Management of dermatology disorders and the pharmacist's role: Acne

    553. Management of dermatology disorders and the pharmacist's role: Common skin conditions

    577. Management of Dermatology Disorders and the Pharmacist's Role: Woundcare

    555. Management of Infectious diseases and the pharmacist's role: Antibiotic stewardship

    556. Management of Infectious diseases and the pharmacist's role: bacterial infections

    557. Management of Infectious diseases and the pharmacist's role: Fungal infections

    558. Management of Infectious diseases and the pharmacist's role: Selection of appropriate regimen

    559. Management of Infectious diseases and the pharmacist's role: Viral Infections

    560. Management of Infectious diseases and the pharmacist's role: Immunisations

    561. Management of Infectious diseases and the pharmacist's role: peri -surgical

    563. Management of Infectious diseases and the pharmacist's role

    564. Nutritional Anemias

    567. Management of oncologic disorders and the pharmacist's role: Cancer treatment and chemotherapy

    569. Management of nutrition disorders and the pharmacist's role: Role of nutrition in different conditions incl obesity

    570. Management of nutrition disorders and the pharmacist's role: Drugs in sport

    571. Clinical Pharmacy considerations in special population: drug dose adjustment in hepatic impairment

    572. Clinical Pharmacy considerations in special population: Geriatrics

    574. Clinical Pharmacy considerations in special population: Pediatrics

    575. Clinical Pharmacy considerations in special population: pregnancy and lactation

    576. Clinical Pharmacy considerations in ICU incl TPN

    352. Philosophical perspective and theories applied in pharmacy practice research

    601. Pharmacy practice research evidence: development and historical narrative

    602. Research methodologies related to pharmacy practice

    603. Quantitative methods in pharmacy practice research

    604. Qualtitative methods in pharmacy practice research

    605. Health Economics Research: An Emerging Pharmacy Practice Discipline

    606. Action research in pharmacy practice

    607. Systematic reviews and meta-analysis in pharmacy practice

    608. Meta synthesis of qualitative research in pharmacy practice research

    609. Mixed methods research in pharmacy practice

    610. Publication bias

    611. Discrete choice experiment

    613. Survey research in pharmacy practice

    614. Challenges in producing and acquiring data to produce evidence based pharmacy practice research

    615. Quality of qualitative research

    616. Clinical pharmacist as a principal investigator in clinical trials

    617. Pharmacy Practice Research Evidence: Gaps in evidence for LMIC

    618. Implementation Science

    701. Medicines Management: The core of pharmacy practice

    702. Historical evolution of pharmacy practice

    703. Pharmacy Codes of Ethics

    704. Community and Ambulatory Pharmacy Practice

    705. Hospital pharmacy practice

    706. Expanded and evolving roles for pharmacists

    707. Cognitive pharmacy services

    708. Prescribing: ethics, standards, practices, behaviours, and competencies

    709. Professionalism in pharmacy practice

    710. The regulation of pharmacy practice

    711. Public health and health promotion in pharmacy practice

    712. Collaborative and interprofesional pharmacy practice

    713. Interpersonal communication in pharmacy practice

    714. Evidence-based pharmacy practice using drug information resources

    715. Patient counselling and education: models and methods in pharmacy practice

    716. Technology and social media applications in pharmacy practice

    717. Pediatric pharmacy practice (including infant feeding)

    718. Use of complementary/alternative medicines in pharmacy practice

    719. Prevention and management of substance misuse and addiction in pharmacy practice

    720. Self care/over the counter drugs/minor ailments in pharmacy practice

    721. Extemporaneous compounding in pharmacy practice

    722. Global Health and pharmacy practice

    723. Pharmacy practice in the United Kingdom

    724. Pharmacy practice in Canada and the United States

    725. Pharmacy Practice in Western Europe

    726. Pharmacy practice in Australia and New Zealand

    727. Pharmacy practices in Southern Africa

    728. Pharmacy practice in China

    729. Pharmacy practice in India

    730. Pharmacy practice in the Gulf States

    731. Pharmacy: a business, a profession, both, or neither?

Product details

  • No. of pages: 2358
  • Language: English
  • Copyright: © Academic Press 2019
  • Published: June 20, 2019
  • Imprint: Academic Press
  • eBook ISBN: 9780128127360
  • Hardcover ISBN: 9780128127353

About the Editor in Chief

Zaheer-Ud-Din Babar

Professor Zaheer-Ud-Din Babar is Professor in Medicines and Healthcare and the Director of Centre of Pharmaceutical Policy and Practice Research at the University of Huddersfield, United Kingdom. He is globally known for his work in pharmaceutical policy and practice, including quality use of medicines, clinical pharmacy practice, access to medicines and issues related to pharmacoeconomics. He has published in high impact journals such as PLoS Medicine and the Lancet and has acted as a consultant for World Health Organization, Royal Pharmaceutical Society, Health Action International, International Union Against Tuberculosis and Lung Disease, World Bank, European Union, International Pharmaceutical Federation (FIP) and for the Pharmaceutical Management Agency of New Zealand. His edited work includes "Economic evaluation of pharmacy services", “Pharmaceutical prices in the 21st century”, “Pharmaceutical policies in countries with developing healthcare systems ", “Global Pharmaceutical Policy”, “Pharmacy Practice Research Methods” and “Encyclopedia of Pharmacy Practice and Clinical Pharmacy”. Published by Elsevier and Adis/Springer, the work is used in curriculum design, policy development and for referral all around the globe. Professor Babar is also the Editor-in-Chief of BMC Journal of Pharmaceutical Policy and Practice and can be contacted at z.babar@hud.ac.uk

Affiliations and Expertise

Professor in Medicines and Healthcare and Director, Centre of Pharmaceutical Policy and Practice Research, University of Huddersfield, UK

Latest reviews

(Total rating for all reviews)

  • Erwin F. Wed Feb 26 2020

    Now indexed in SCOPUS

    Congratulations to the team! Now indexed in SCOPUS.. It was first time that Philippines will be highlighted in the International arena on its pharmacy practice especially on this prestigious book. Congratulations to my team.. Sir Edward Tolentino and Ravina... Job well done. Congratulations to Professor Zaheer Babar and the whole team.

  • Samra B. Mon Aug 26 2019

    Encyclopedia of Pharmacy Practice and Clinical Pharmacy

    The Encyclopedia of Pharmacy Practice and Clinical Pharmacy by Professor Zaheer-ur-din Babar is a great contribution and service to the emerging field of Pharmacy Practice and Clinical Pharmacy. It will surely benefit the students, academicians, researchers, and practitioners and will strengthen relevant areas of the Pharmacy profession. Congratulations to Professor Babar on this accomplishment.

  • Rabia K. Wed Aug 21 2019

    Highly recommended to those who aim to be successful!

    The Encyclopedia of Pharmacy Practice and Clinical Pharmacy is a comprehensive compilation that covers almost all the possible areas of Pharmacy Practice and Research, Social and Administrative pharmacy, Pharmacoepidemeology, Pharmacovigilence, Clinical Pharmacy, Pharmacotherapy and Clinical Pharmacy Education. One would hardly find such extensive information in any other book of facts. The global acceptance of this book can be predicted by the diversity of authors contributing to this masterpiece. I truly appreciate the efforts of the Editor-in-Chief Dr.Zaheer Babar who efficiently manage such a huge pool of information in a decently organized fashion in four Volumes. The thing I like the most about this book is the way it caters its loyal readers by proving the ‘Further Reading’ and ‘Relevant Websites’ section at the end of almost every chapter. I highly recommend this valuable resource to students, colleagues and other health care professionals who wish to seek expertise in the field and a guide to the future of pharmacy.

  • Sheraz A. Wed Jul 03 2019

    Congratulations

    Another great contribution by Prof Zaheer Babar.

  • Nasira S. Tue Jul 02 2019

    Encyclopedia of Pharmacy Practice and Clinical Pharmacy

    Dr. Zaheer-Ud-Din Babar has contributed an excellent count to the science Literature in the field of pharmacy. Being country fellow, I am very proud of him for his global recognition of research in pharmaceutical policy and practice, clinical pharmacy practice and Pharmacoeconomics. Professor Babar and all contributors deserve appreciations, congratulations and Best wishes.